clairvoyant-dx.com

Clairvoyant diagnostics GmbH is a Berlin-based company founded in 2021, supporting the development and improvement of innovative biochemical and immunological assays. Its interdisciplinary team of scientists and biotechnologists brings decades of experience in immunology, protein biochemistry and diagnostics. The company develops, characterizes, validates and refines assays, including EIA, ELISA, LIA and LFA formats, with a focus on high sensitivity and specificity. It also applies expertise in post-translational protein modifications to enhance diagnostic performance.

Beyond assay development, Clairvoyant diagnostics provides microbial analysis, growth analysis using selection media, and DNA sequencing. Its protein services include production and quality assessment of proteins, enzymes and antibodies, with evaluation of purity, stability and functionality. The company also offers biomarker profiling and consulting, drawing on its knowledge of the diagnostic market and relevant certification and accreditation processes. Clairvoyant diagnostics welcomes collaborations on grant applications and joint projects, working with customers and partners to advance diagnostic solutions. Its services span the development process, from technical refinement to quality analysis and market-informed guidance.